Equity Capital Markets

Company · CIK 1776111

MBX Biosciences, Inc.

Source: SEC EDGAR · as of 2026-10-27 06:30 UTC · latest filing day 2026-10-26

CIK1776111 (SEC EDGAR)
Industry (SIC)2834 — Pharmaceutical Preparations
Incorporated inDE
Business addressIN
ListedMBX (Nasdaq)
First annual or quarterly report2024-11-07

Offerings

4 registrations
RegistrationLabel and statusFirst filedLast eventFilings
333-294237
ShelfEffective
 2026-03-122026-03-121
333-291308
ShelfEffective
 2025-11-062025-12-082
333-290447
Registered companyFinal prospectus
 2025-09-222025-09-253
333-281764
First-time registrationEffective
 2024-08-232024-09-135

Filings

13
FiledFilingRegistrationAccession
2026-03-12S-3ASRShelf registered 333-2942370001193125-26-104097
2025-12-08EFFECTDeclared effective 333-2913089999999995-25-003581
2025-11-06S-3Shelf registered 333-2913080001193125-25-268202
2025-09-25424B4Final prospectus 333-2904470001193125-25-217429
2025-09-24EFFECTDeclared effective 333-2904479999999995-25-003084
2025-09-22S-1Registration filed 333-2904470001193125-25-211320
2025-08-08DRSDraft made public 377-083070000950123-25-007329
2024-09-13424B5Shelf takedown 333-2817640001193125-24-218860
2024-09-12EFFECTDeclared effective 333-2817649999999995-24-002818
2024-09-09S-1/AAmendment 333-2817640001193125-24-215436
2024-08-30S-1/AAmendment 333-2817640001193125-24-211217
2024-08-23S-1Registration filed 333-2817640001193125-24-206227
2024-03-22DRSDraft made public 377-071470000950123-24-002979

All filings of this company · CSV